Telomir Pharmaceuticals (TELO) Enterprise Value: 48.62M

Telomir Pharmaceuticals, Inc. (TELO)

0.88 +0.10 (+12.81%) USD | NASDAQ | Nov 06, 10:28

Enterprise Value Chart

Historical Enterprise Value Data

View and export this data back to 2024. Start Trial.

Date	Value
November 05, 2026	48.62M
November 04, 2026	55.14M
November 03, 2026	57.55M
November 02, 2026	57.90M
October 30, 2026	59.28M
October 29, 2026	61.28M
October 28, 2026	64.43M
October 27, 2026	65.12M
October 26, 2026	63.64M
October 23, 2026	62.03M
October 22, 2026	64.43M
October 21, 2026	65.12M
October 20, 2026	64.43M
October 19, 2026	66.49M
October 16, 2026	67.18M
October 15, 2026	67.18M
October 14, 2026	67.18M
October 13, 2026	69.93M
October 12, 2026	70.62M
October 09, 2026	71.99M
October 08, 2026	74.06M
October 07, 2026	71.99M
October 06, 2026	77.50M
October 05, 2026	78.18M
October 02, 2026	76.12M

Date	Value
October 01, 2026	75.43M
September 30, 2026	77.50M
September 29, 2026	75.43M
September 28, 2026	77.50M
September 25, 2026	79.56M
September 24, 2026	78.18M
September 23, 2026	78.87M
September 22, 2026	80.93M
September 21, 2026	80.25M
September 18, 2026	79.56M
September 17, 2026	71.99M
September 16, 2026	72.68M
September 15, 2026	75.43M
September 14, 2026	75.43M
September 11, 2026	75.43M
September 10, 2026	76.12M
September 09, 2026	78.87M
September 08, 2026	76.81M
September 04, 2026	74.75M
September 03, 2026	74.75M
September 02, 2026	71.99M
September 01, 2026	70.62M
August 31, 2026	71.99M
August 28, 2026	73.37M
August 27, 2026	76.81M

Enterprise Value Definition

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks